Before NACT, sHLA-Gfree levels are exclusively related to estrogen receptor expression, whereas high amounts of HLA-G in EVs (sHLA-GEV) enriched from peripheral blood samples are associated with the existence of circulating stem cell-like tumor cells. This evidence concerns the gene HLA-G and neoplasm.